What is the standard treatment regimen for H. Pylori (Helicobacter Pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Standard Treatment Regimen for H. Pylori Infection

Bismuth quadruple therapy for 14 days is the recommended first-line treatment for H. pylori infection, especially in areas with high clarithromycin resistance (≥15%). 1

First-Line Treatment Options

Bismuth Quadruple Therapy (Preferred)

  • Components:
    • Proton pump inhibitor (PPI): Esomeprazole 20-40 mg twice daily
    • Bismuth subsalicylate: 2 tablets (262 mg each) four times daily
    • Tetracycline: 500 mg four times daily
    • Metronidazole: 500 mg three to four times daily
  • Duration: 14 days
  • Eradication rate: Approximately 85%
  • Key administration details:
    • PPIs should be taken 30 minutes before meals
    • Bismuth should be taken 30 minutes before meals
    • Antibiotics should be taken 30 minutes after meals

Alternative First-Line Options

  • Triple therapy (in areas with low clarithromycin resistance):

    • Amoxicillin 1 gram twice daily
    • Clarithromycin 500 mg twice daily
    • PPI (e.g., lansoprazole 30 mg) twice daily
    • Duration: 14 days 2
  • Dual therapy (for patients allergic/intolerant to clarithromycin or with suspected resistance):

    • Amoxicillin 1 gram three times daily
    • PPI (e.g., lansoprazole 30 mg) three times daily
    • Duration: 14 days 2

Second-Line Treatment Options

If first-line treatment fails, consider:

  • Levofloxacin-based therapy: Especially if the patient has previous exposure to metronidazole 1
  • High-dose dual therapy: After failure of clarithromycin-based and bismuth quadruple therapies 1
  • Rifabutin-containing therapy: Reserved for patients who have failed multiple treatment attempts 1, 3

Treatment Monitoring and Confirmation

  • Confirm eradication 4 weeks after completing treatment using:
    • Urea breath test (preferred, 95% sensitivity, 90% specificity)
    • Monoclonal stool antigen test
  • Stop PPI 2 weeks before testing to avoid false negatives 1

Special Considerations

Penicillin Allergy

  • Bismuth quadruple therapy is the preferred first-line treatment for patients with true penicillin allergy 1

Treatment Failures

  • Avoid re-using antibiotics that failed previously, particularly clarithromycin and levofloxacin 1
  • For persistent infection after optimized bismuth quadruple therapy, rifabutin triple therapy for 14 days is recommended 3

Medication Selection Tips

  • Not all PPIs are equivalent - esomeprazole 20 mg is equivalent to 32 mg of omeprazole, while pantoprazole 40 mg is only equivalent to 9 mg of omeprazole 1
  • Separate PPI (before meals) from antibiotics (after meals) to maximize efficacy 1

Common Pitfalls to Avoid

  • Using shorter courses (7-10 days) instead of the recommended 14 days reduces eradication rates 1
  • Not considering local resistance patterns, especially in areas with high clarithromycin resistance 1, 4
  • Failing to confirm eradication after treatment completion 1
  • Not stopping PPI before confirmation testing (can lead to false negatives) 1

For patients with gastric ulcers, endoscopy should be performed approximately 6 weeks after discharge to confirm healing and exclude malignancy, with continued PPI therapy until follow-up endoscopy 1.

References

Guideline

H. pylori Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.